Découvrir nos dernières publications
Septembre à décembre 2025
Pathway coessentiality mapping reveals complex II is required for de novo purine biosynthesis in acute myeloid leukaemia
Stewart, A.E., Zachman, D.K., Castellano-Escuder, P. et al.
Nat Metab 7, 2474–2488 (2025).
Age‐adapted chemotherapy and MRD‐oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial
Immune intervention is dispensable for retinoic acid/arsenic therapy of murine acute promyelocytic leukemia.
Esnault C, Fortin G, Qiu F, Soilihi H, Souquère S, Niwa-Kawakita M, Lanchais K, Dirami T, Pierron G, De Thé H.
Haematologica. 2025 Sep 11.
LEF1 intragenic deletion induces a dominant-negative isoform and unveils a Wnt/β-catenin vulnerability in T-ALL
Delafoy M, Bonnet MF, Lengliné E, Cieslak A, Touzart A, Balducci E, Simonin M, Lhéritier V, Dourthe ME, Heid-Picard B, Latour S, Dombret H, Rousselot P, Baruchel A, Boissel N, Andrieu GP, Asnafi V.
Blood. 2025 Dec 18;146(25):3036-3049
VEXAS anemia is a mosaic erythroblastopenia
Rodrigues F, Hardouin G, El Hoss S, Ghoul A, Gautier EF, Dussiot M, A Lizarralde-Iragorri M, Santini A, Peltier S, Amireault P, Soldan V, Miccio A, Debili M, Jachiet V, Trovati Maciel T, Rossignol J, Allemand E, Mékinian AM, Georgin-Lavialle SA Pr, Salma M, Soler E, Gleizes PE, O’Donohue MF, Kosmider O, Rodriguez MS, Hermine O.
Blood. 2025 Sep 19:blood.2025029081.